Middle East & Africa newborn screening market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.
Get More Insights About Middle East and Africa Newborn Screening Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=middle-east-and-africa-newborn-screening-market
SegmentationMiddle East and Africa Newborn Screening Market
On the basis of test type, the market is segmented into dried blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test
On the basis of product type, the market is segmented into instruments, reagents & assay kits
On the basis of technology, the market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, DNA-based assays
On the basis of disease type, the market is segmented into phenylketonuria (PKU), cystic fibrosis (CF), sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease, others
On the basis of end user, the market is segmented into pediatric clinics, hospital, clinics
Know more about this report https://www.databridgemarketresearch.com/reports/middle-east-and-africa-newborn-screening-market
Competitive Analysis: Middle East and Africa Newborn Screening Market
Some of the major players operating in the Middle East & Africa newborn screening market are PerkinElmer Inc., Natus Medical Incorporated, Trivitron Healthcare, Baebies, Inc., Bio-Rad Laboratories, Inc., Danahar, Hill-Rom Services Inc., Intelligent Hearing Systems, Interacoustics A/S, Masimo, Medtronic, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A., among others.
In September 2019, Masimo continued Haemoglobion monitoring to investigate the detection of perioperative anemia. The research helped to investigate in the detection of anemia using intermittent haemoglobin monitored using SPHB. The researchers found a delay in the detection of anemia which was later associated with median perioperative with low SPHB and thus improved patient outcomes.
In September 2019, Medtronic announced the clinical data from Onyx Global Study to represent the multi centre, randomized clinical outcomes in nearly 2000 high bleeding patients. The study provides advances for physicians to determine DAPT (dual antiplatelet therapy) followed by PCI among high bleeding patients. The evidence for the approval of the product was to help clinicians respond to the needs of better clinical practice.
In January 2017, PerkinElmer, Inc., had announced its acquisition with Tulip Diagnostics Private Limited. With this the company had developed its emerging market in diagnostics. It also enhances its ability to screen the infectious diseases. Hence there will be increased diagnostics portfolio around the globe.
Research Methodology: Middle East and Africa Newborn Screening Market
Request for Detailed TOC https://www.databridgemarketresearch.com/toc/?dbmr=middle-east-and-africa-newborn-screening-market
Browse Trending Related Reports @
About Data Bridge Market Research: